Plain-English translation of NCT07228117 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new insulin pump system called the MiniMed NMX8 to make sure it is safe and effective for people with diabetes. You would wear the NMX8 pump along with a continuous glucose monitor (a small sensor that tracks your blood sugar) for about 3 months. The research team wants to understand how well the pump works and whether it helps keep your blood sugar in a safe range.
Insulin pumps can help people with diabetes manage their blood sugar more easily, but doctors need to make sure new pump systems are safe before more people can use them. This trial will help determine whether this treatment works well and is ready for wider use.
You likely qualify if…
You likely don't qualify if…
You would first wear just the glucose sensor (without the pump) for up to 40 days while keeping a log of your meals and exercise. Then you would be randomly assigned to one of three groups: one group will not give themselves insulin boluses for meals, another group will give insulin for all meals, and the third group can choose whether to give insulin for meals. You would use the NMX8 pump for about 90 days, continue logging your meals and exercise, and upload your pump data regularly. If you like the pump at the end, you may be able to continue using it in a follow-up program.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States